Gender Affirming Hormone Therapy: What Changes, In What Order, and Why Supervision Matters
Gender affirming hormone therapy is a supervised medical treatment in which specific hormones are given so that physical changes develop gradually in line with transition goals. Changes arrive in a set order rather than all at once, and the reason it needs monitoring is that the effects are systemic, not cosmetic.
Written by Dr. Ashutosh A Shah, M.B.B.S., M.S., M.Ch., D.N.B., Board Certified Plastic Surgeon, Elegance Transgender Clinic, Surat. Reg. no. [REG NO]. 22+ years in plastic and reconstructive surgery.
Medically reviewed by Dr. Ashutosh A Shah · Published 29 September 2026 · Last reviewed 29 September 2026
Gender affirming hormone therapy is a supervised medical treatment in which specific hormones are given so that physical changes develop gradually in line with transition goals. Changes arrive in a set order rather than all at once, and the reason it needs monitoring is that the effects are systemic, not cosmetic.
Most people arrive at this subject with two questions that rarely get answered together: what will actually change, and how closely does this need to be watched.
This page answers both. It covers what hormone therapy is, the order changes arrive in, which of them reverse and which do not, what is checked along the way, and what has to be settled before anything starts. It does not describe any medicine, dose or schedule, because those belong in a consultation with the clinician who is responsible for you, and nowhere else.
What is gender affirming hormone therapy, and what is it not?
It is a medical treatment that changes the body's hormone levels so that physical characteristics develop in line with a person's gender identity. It is not a cosmetic procedure and it is not a single event.
Mayo Clinic describes the mechanism in one line: "Feminizing hormone therapy is used to change the body's hormone levels." The masculinising equivalent is worded identically: "Masculinizing hormone therapy is used to change the body's hormone levels." The effect is described the same way for both: "Those hormone changes trigger physical changes that help better align the body with a person's gender identity."
Two terms are worth having straight, because you will meet both:
- Feminising hormone therapy. Shifts the body towards the characteristics that develop under a typically female hormone profile.
- Masculinising hormone therapy. Shifts the body towards the characteristics that develop under a typically male hormone profile.
What it is not is equally worth stating. It is not a course you finish. It is not something that works faster if more is taken. And it is not interchangeable with surgery, which is a separate set of decisions covered in section eight.
Why is it a medical treatment rather than a prescription you collect?
Because it changes systems, not surfaces. The hormones involved act on bone, blood, liver, cardiovascular risk and mood as well as on the features people are hoping to change.
That is the reason every reputable source treats the starting point as a conversation rather than a transaction. Mayo Clinic is explicit about it: "You should start feminizing hormone therapy only after you've talked about the risks and benefits, as well as all treatment options available to you, with a healthcare professional who has expertise in transgender care." The masculinising page carries the same sentence.
Read what that sentence actually requires. Not a doctor. Not a pharmacy. A healthcare professional with expertise in transgender care, having discussed risks, benefits and the alternatives. Each of those three parts is doing work.
The standards most gender clinics work to are the WPATH Standards of Care, Version 8, which set out how gender affirming care is assessed and delivered. A clinic that cannot tell you what framework it works to is worth a second question.
What changes, and in what order?
Changes arrive in a sequence rather than together, and the sequence is more predictable than the pace. Some things begin early and some take the longest part of the course.
This page gives no month figures, and that is deliberate. Published ranges exist and your clinician will discuss them, but a range lifted onto a page becomes a date people start counting from, and then measure themselves against. What is genuinely useful in advance is the order and whether a change reverses.
| Type of change | Roughly where in the course it begins | Does it reverse if treatment stops |
|---|---|---|
| Skin texture and body fat distribution, feminising | Among the earliest | Largely reverses |
| Breast development, feminising | Begins early, completes slowest | Does not reverse |
| Reduction in body and facial hair growth, feminising | Gradual, over the longest period | Partly reverses |
| Periods stopping, masculinising | Among the earliest | Usually reverses |
| Body fat redistribution and muscle change, masculinising | Early to middle | Largely reverses |
| Voice deepening, masculinising | Middle of the course | Does not reverse |
| Growth of body and facial hair, masculinising | Middle, and continues | Does not reverse |
| Genital growth and scalp hair loss, masculinising | Variable | Does not reverse |
Read the third column first. It is the one that matters before starting, and it is the subject of the next section.
Which changes are reversible and which are not?
Most of the early changes largely reverse if treatment stops. A specific group does not, and that group should be understood before the first prescription rather than after it.
Mayo Clinic states the general position for feminising therapy: "Some of the physical changes caused by feminizing hormone therapy can be reversed if you stop taking it." It then names the exception: "Others, such as breast development, cannot be reversed."
For masculinising therapy the irreversible group is larger, and Mayo Clinic lists it plainly: "Others, such as a deeper voice, a larger clitoris, scalp hair loss, and more body and facial hair, cannot be reversed."
Three honest observations about that list:
- It is not a warning. For most people these are the changes they are seeking, and permanence is the point rather than the risk.
- It is a reason to start informed rather than quickly. A change you wanted and a change you cannot undo can be the same change.
- It shapes the order of other decisions. Breast development being irreversible is why chest surgery is assessed after hormone therapy has done what it is going to do, which is set out on our post about breast augmentation after hormone therapy.
Why can the pace not be rushed?
Because the body responds to hormone levels over time rather than to the amount given at once. More does not mean faster, and it does mean more risk.
This matters because the strongest pressure people feel is to hurry. Waiting is genuinely hard when the gap between how you look and who you are is the thing causing the distress. The honest answer is that the sequence is biological and it will not compress.
What rushing actually produces:
- The same changes, no sooner. Tissue responds at the rate tissue responds.
- Higher risk to the systems in section two. The organs carrying that load do not benefit from speed.
- Monitoring that no longer reflects what is happening, if the treatment being monitored is not the treatment actually being taken.
The useful thing to bring to an appointment is the fact that you feel the pace is too slow. It is a legitimate thing to say and it belongs in the room, not in a workaround.
What is monitored, and why is blood work part of the treatment?
Regular review with the clinician, and blood tests looking well beyond hormone levels. The tests exist because the treatment reaches systems that have nothing to do with appearance.
Mayo Clinic describes the review itself: "While on masculinizing hormone therapy, you meet regularly with your healthcare professional to: Keep track of your physical changes."
On the blood work, it is specific about what is being looked for: "Have blood tests to check for changes in your cholesterol, potassium, blood sugar, blood count, and liver enzymes that could be caused by hormone therapy."
Look at that list again, because it explains the whole of this page. Cholesterol, potassium, blood sugar, blood count and liver enzymes are not measures of how a transition is going. They are measures of whether the rest of the body is tolerating the treatment. That is the difference between a medical treatment and a cosmetic one, and it is why monitoring is not administrative.
Two practical points that follow:
- Missed reviews are not a minor lapse. The treatment continues whether or not anyone is watching it.
- Tell your clinician about everything else you take. Interactions are checked at these appointments and nowhere else.
What has to be decided before starting?
Fertility, above everything else, because that decision narrows once treatment begins. Mayo Clinic puts it in two sentences: "Feminizing hormone therapy may limit fertility." and "The risk of permanent infertility increases with long-term use of hormones."
That is the whole of what this page says about it, deliberately, because it deserves a page rather than a paragraph. What to decide, what the options are, what is realistic in India and what the law allows are all set out on our post about fertility before gender affirming treatment. If nobody has raised this with you before offering treatment, that is itself worth noticing.
What does hormone therapy not do, and what is separate?
It does not change bone structure that has already formed, and it is not a substitute for surgery where surgery is what a person wants. Those are separate questions with separate answers.
The NHS lists what sits alongside it for adults, and hormone therapy is one item among several: "hormone therapy", "voice and communication therapy", "talking therapy and counselling", and "surgery to change parts of the body (gender reassignment surgery)".
Read that as a menu of separate things rather than a sequence everybody completes. Some people have hormone therapy and no surgery. Some have voice work and nothing else. The list is not a ladder.
Where surgery is part of someone's plan, the results and the timing are their own subject. Chest surgery is covered on our post about what a good chest result involves, and breast augmentation after hormone therapy on its own page. This page does not describe either.
Why is starting without supervision the real risk?
Because the part that needs a doctor is the part you cannot see. Unsupervised hormone use is not risky because the hormones are exotic. It is risky because nobody is watching the systems in section six.
This needs saying without lecturing anybody. People start without supervision for reasons that are usually practical: no specialist within reach, cost, waiting, or a past experience of being treated badly by a clinician. Those are real problems and none of them is the person's fault.
What is lost when supervision is absent, specifically:
- Nobody is checking the bloods. Changes in liver enzymes, blood count and blood sugar produce no symptoms until they are advanced.
- Nobody is checking interactions with anything else being taken.
- Nobody is adjusting anything. Treatment that is never reviewed is treatment that cannot respond to how you are actually doing.
- There is no record. That record is what any future clinician, including a surgeon, needs.
Mayo Clinic's condition for starting is the standard to hold anyone to, including us: treatment should begin "only after you've talked about the risks and benefits, as well as all treatment options available to you, with a healthcare professional who has expertise in transgender care."
If you have already started without supervision, the useful step is not to stop and say nothing. It is to tell a clinician what you have been taking, so that monitoring can begin from where you actually are.
How is gender affirming hormone therapy assessed at Elegance Transgender Clinic, Surat?
By establishing what someone is seeking, what has already been started, and what has not yet been discussed, before anything is planned.
In our practice in Surat, the most common thing we see is someone who has already begun, often for months, without any blood work and without anyone having raised fertility with them. They are frequently expecting to be told off, and that is not what the appointment is for. The useful part is getting monitoring started and filling in the decisions that were skipped.
An assessment covers what is being taken and for how long, what has and has not been monitored, what changes are wanted and which of those hormones can deliver, whether fertility has been discussed, and where surgery does or does not fit. Where treatment belongs with an endocrinologist rather than with us, that is what will be arranged.
What you will not be asked to do is justify yourself.
Next step
If you are considering hormone therapy, or have already started and want it monitored properly, the useful step is an assessment rather than more reading. You can book a consultation to discuss what you are seeking, what has already been started, and what needs to be checked.
This page is for education and is not a substitute for professional assessment. It deliberately describes no medicine, dose or schedule, because those belong with the clinician responsible for your care. Discuss your own situation with Dr. Ashutosh A Shah, an endocrinologist, or another qualified clinician with experience in transgender care.